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Abstract
Children diagnosed with attention-deficit/hyperactivity disorder (ADHD) often
suffer from impulsivity which makes the navigation of many novel, real-world scenarios
particularly cumbersome. Recent studies have shown that an attenuated expression of
latrophilin 3 (Lphn3) gene is linked to a dampening of extracellular dopamine (DA)
levels that is both temporally and spatially consistent with the ADHD pathology
expressed in humans. Importantly, the disruptions in DA transmission reported to occur
as a result of Lphn3 variation also result in impulsivity deficits that mirror those that are
observed in humans suffering from ADHD. The present study aimed to assess two
different facets of impulsivity including impulsive action and impulsive choice to offer a
more explicit and complete assessment of the influence of Lphn3 variation on impulsive
behavior. Compared to wildtype (WT) controls (i.e., Lphn3+/+), Lphn3 knockout (KO)
rats (i.e., Lphn3-/-) exhibited a lower ratio of reinforced:non-reinforced responses when
assessed on a differential reinforcement of low rates (DRL) task indicative of a deficit in
impulsive action. When evaluating impulsive choice using a delay discounting (DD) task,
the KO rats discounted the larger, delayed reward significantly less than the WT rats,
indicating that the delays used in this experiment did not produce a deficit in impulsive
choice in the KO rats. Overall, these results suggest a dissociation in how Lphn3 variation
affects impulsivity, with impulsive action, but not impulsive choice, being negatively
affected.
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Impulsivity in the ADGRL3 (LPHN3) Knockout Rodent: Relevance to AttentionDeficit/Hyperactivity Disorder
Introduction
Executive functions (EF) are a collection of top-down mental processes that
include higher-order cognitive abilities such as inhibitory control (practicing selfcontrol), cognitive flexibility (perspective switching or “thinking outside of the box”) and,
working memory (manipulating information held in mind) (Diamond, 2013). EF play an
important role in preserving both mental and physical health, allowing for optimal
academic, professional, and/or social development, and promoting an overall positive
quality of life. Deficits in inhibitory control are often characterized as impulsivity and
have been postulated to contribute to several different externalizing disorders including
attention deficit/hyperactivity disorder (ADHD), oppositional defiant disorder, and
substance use disorder (Kozak et al., 2018; Lee, Hoppenbrouwers, & Franken, 2019;
Martel, Levinson, Lee, & Smith, 2017).
Facets of Impulsivity
It is important to point out that impulsivity is a multi-faceted construct.
Researchers have proposed three broad categories: impulsive action, impulsive choice,
and impulsive personality traits (Broos et al., 2012; Dalley & Robbins, 2017; MacKillop
et al., 2016). Impulsive action is typically defined as the inability to inhibit a prepotent
motor response while impulsive choice is the tendency to select smaller immediate
rewards over larger delayed rewards. Both impulsive action and impulsive choice have
been reliably tested in animals and humans (Bari & Robbins, 2013; Broos et al., 2012;
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Dalley & Robbins, 2017). Impulsivity as a personality trait is typically based on selfreport and therefore is not measurable in non-human subjects (MacKillop et al., 2016).
Prefrontal Catecholamines Modulate Impulsivity
Modulation of catecholamine dependent neurotransmission is essential for
guiding optimal prefrontal cortex function (PFC) – the neural structure that gives rise to
EF, including the various facets of impulsivity (Robbins & Arnsten, 2009). Lesions of the
PFC are known to produce behavioral symptoms including impulsivity. For example,
lesions of the medial PFC (mPFC) result in impaired performance on a differential
reinforcement of low rates (DRL) task which is a commonly used measure of impulsive
action (Sokolowski & Salamone, 1994). In the case of impulsive choice using a delay
discounting (DD) paradigm, ischemic lesions of the medial orbital PFC (oPFC) in rats
produced a shift whereby lesioned rats were less likely than controls to press a lever
associated with a larger, delayed reward and instead press a lever associated with an
immediate but smaller reward. Interestingly, discounting in rats that were given ischemic
lesions of the mPFC did not differ from controls (Deziel & Tasker, 2017). However,
other studies have shown antagonism of DA D1 and D2 receptors in the mPFC increases
impulsive choice (Pardey, Kumar, Goodchild, & Cornish, 2013). Overall, the DRL and
DD results suggest that, in addition to the behavioral dissociation between impulsive
action and impulsive choice, there is likely some degree of a neurobiological dissociation
as well. Dalley and Robbins (2017) discuss these unique impulsivity networks,
particularly the unique role for the oPFC for DD.
Importantly, either too much or too little catecholamine activity has been
associated with alterations in impulsivity. Systemic injection of higher doses of d-
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amphetamine (AMPH) has been shown to impair DRL (Fowler, Pinkston, & Vorontsova,
2009; Sable, Eubig, Powers, Wang, & Schantz, 2009; Sabol, Richards, Layton, & Seiden,
1995; Seiden, Andresen, & MacPhail, 1979) and DD performance (Krebs, Reilly, &
Anderson, 2016) and direct infusion of D1 and D2 antagonists into the mPFC can
counteract the impairing effects of AMPH (Cheng & Liao, 2017). However, systemic
administration of selective norepinephrine (NE) inhibitors increased extracellular levels
of norepinephrine in the mPFC and altered DRL performance in a manner that has been
shown to be dose-dependent. The selective norepinephrine inhibitors desipramine,
nortriptyline, and reboxetine increased DRL reinforcement rates at lower doses but
decreased reinforcers earned at higher doses (Dekeyne, Gobert, Auclair, Girardon, &
Millan, 2002). Given the inverted U-shaped influence that DA and NE transmission
have, the impact of dose must be considered relative to baseline level of performance.
Treatment with AMPH improved DD performance in rats that had a high, but not low,
baseline level of impulsive choice (Krebs & Anderson, 2012). Clinically, AMPH has
been shown to improve impulsive behavior, particularly when individuals exhibited
decreased baseline performance (Pattij & Vanderschuren, 2008).
Catecholamine Function and ADHD
Interestingly, neuro-imaging studies have revealed that there is reduced
prefrontocortical brain volume, consistently abnormal DA dependent fronto-executive
activity (Russell, 2011), and decreased uptake of 6-[18f]-L-DOPA in individuals
suffering from attention-deficit/hyperactivity disorder (ADHD) (Dalley, Mar,
Economidou, & Robbins, 2008) – a neurobehavioral disorder characterized by impulsive
behavior. An estimated 8% of children are diagnosed with ADHD, and approximately
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50% of diagnosed children will experience symptoms that persist into adulthood (Lakhan
& Kirchgessner, 2012).
In recent years, the growing rates of diagnoses in conjunction with the increasing
acceptance of popular ADHD medications have led to considerable increases in
prescribing rates (Graf, Miller, & Nagel, 2014). Because ADHD is currently diagnosed
with DSM-IV criteria and is often comorbid with several other disorders and increased
prescribing rates, this makes accurate and consistent clinical diagnoses difficult and
magnifies the potential for over-treatment (Madras, Miller, & Fischman, 2005). As a
result, psychostimulants, the class of medications that include those that have shown to
be most effective in treating ADHD, have become more accessible for illicit use (Lakhan
& Kirchgessner, 2012).
Thus, a growing body of research has been aimed toward understanding the
multifactorial association between catecholamine activity and ADHD. One important
parallel is that all functions that are facilitated by normal fronto-executive activityimpulsivity, locomotor activity, attentional regulation, working memory, etc.- have been
reported to be impaired in ADHD patients (Meneses et al., 2011; Russell, 2011;
Sagvolden, 2000). From a neurobiological perspective, it is well documented that ADHD
is associated with significant alterations along dopaminergic pathways in the brain
(Bowton et al., 2010; Del Campo, Chamberlain, Sahakian, & Robbins, 2011; Madras et
al., 2005; Russell, 2003), namely cortico-limbic-striatal networks involving projections
that originate in the PFC and descend outward to the striatum and nucleus accumbens
(Dalley et al., 2008). However, researchers have failed to identify an exact
neurobiological mechanism for ADHD which is likely attributable to the lack of
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consistency in medication history, imaging technique, and age of subjects that have been
used in past studies (Del Campo et al., 2011).
Nonetheless, it is consistently reported that DA depletion along corticostriatal
pathways contributes to ADHD symptomology; because, 1) this pathway is linked to
impulsive behavior associated with ADHD, and 2) the vast majority of genes implicated
in ADHD are involved in various aspects of DA transmission including activity of
dopamine transporter (DAT), norepinephrine transporter (NET), DA β-hydroxylase, and
the expression of synaptosomal-associated protein-25 (SNAP-25) (Madras et al., 2005).
Additionally, neuroimaging studies of ADHD patients have revealed consistent
hypoactivity of the frontal cortex, subcortical structures, and cerebellar cortex
accompanied by hyperactivity of sensorimotor areas which were all reversible by
treatment with psychostimulants (Russell, 2003). Moreover, the wealth of convergent
evidence indicating that the most common and most effective treatments for ameliorating
ADHD symptomology are psychostimulants (drugs that facilitate catecholamine
transmission) is, perhaps, the strongest evidence that dopamine hypoactivity in the brain
is a likely neurobiological substrate of ADHD (Del Campo et al., 2011; Madras et al.,
2005; Russell, 2003).
Methylphenidate (MPH) and amphetamine (AMPH) are currently the most
commonly prescribed psychostimulant medications for the treatment of ADHD (Bowton
et al., 2010; Del Campo et al., 2011; Madras et al., 2005; Russell, 2003, 2011; Sagvolden,
2000). MPH and AMPH both increase extracellular catecholamine concentrations by
preventing the reuptake of DA and NE through modulation of their transporters (DAT
and NET, respectively). However, unlike MPH, AMPH also produces reverse transport
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and inhibits catabolism of these neurotransmitters (Madras et al., 2005). Thus, AMPH
and MPH are thought to relieve the abnormally increased impulsive behavior associated
with ADHD through the correction of the hypodopaminergic neural state. Single photon
emission computed tomography (SPECT) studies have revealed increased density of
striatal DAT in ADHD patients (Russell, 2003). This is significant because a) this
abnormality in DAT expression is compatible with the neural state of the most commonly
studied animal models for ADHD (Madras et al., 2005; Russell, 2011) b) increased DAT
density suggests increased reuptake which could possibly result in abnormally depleted
extracellular DA levels, and c) psychostimulant treatment has been shown to decrease
DAT availability in ADHD patients (Russell, 2003). Thus, the DAT has long been a
primary candidate for investigating the pathophysiology of ADHD and potential
pharmaceutical intervention options.
In addition to DAT, NET seems to also play a prominent role in the sequestration
of extracellular DA. For example, atomoxetine, a selective NET inhibitor, has been
shown to be effective in treating ADHD symptomology. Importantly, atomoxetine has
been shown to increase extracellular DA levels in rodent PFC, while concentrations in
subcortical regions (striatum and nucleus accumbens) remained unchanged (Russell,
2003). The localized effects of atomoxetine are best explained by the heterogeneity of
regional expression that DAT and NET exhibit (Bradshaw, Agster, Waterhouse, &
McGaughy, 2016). Specifically, compared to DAT, NET has a higher binding affinity for
DA and is more densely populated in the PFC, while the opposite is true in the striatum.
Thus, in the PFC, DA reuptake primarily occurs through the action of NET. This is
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further confirmed by the typical clearance of synaptic DA in the PFC of DAT knockout
mice (Moron, Brockington, Wise, Rocha, & Hope, 2002).
Lphn3 and ADHD
Given the wealth of ADHD research converging on the theory of disruptions in
communication between catecholaminergic neural structures, past studies have attempted
to recreate the ADHD phenotype in several rodent models by either genetically,
environmentally, or by pharmacologically manipulating catecholamine transmission in
the PFC. The latrophilin 3 gene null rodent (Lphn3-/-) has emerged as one of the more
prominent genetically modified animal models used for studying ADHD symptomology.
Also referred to as the adhesion G-protein coupled receptor L3 gene (Adgrl3), Lphn3 is a
G-protein coupled receptor (GPCR) that is almost exclusively expressed in the brain and
interacts with the endogenous fibronectin family of leucine-rich repeat transmembrane
protein 3 (Flrt3) ligand (Acosta et al., 2016). Flrt3 is involved in processes such as cell
adhesion, neuronal signaling, and synaptic organization. Disruptions in Flrt3 function
have been shown to lead to reductions in excitatory synapse density and a weakened
afferent input (Orsini et al., 2016). As a GPCR the interaction between Lphn3 and Flrt3
plays an important role in transmembrane signaling, Ca2+ mobilization from presynaptic
stores, neuronal structure, and synaptic development (Acosta et al., 2016; Orsini et al.,
2016). Lphn3 also can interact with Shank proteins. Interference in Shank protein
functioning is linked to abnormal structural changes in dendritic spines as well as defects
in corticostriatal circuitry (Orsini et al., 2016). Additionally, research on zebrafish
populations has shown that a lack of Lphn3 is linked to alterations in DA cell counts,
extracellular DA levels, DAT populations, a globally altered sensitivity to DA agonists

7

(Lange, Froc, Grunwald, Norton, & Bally-Cuif, 2018) and altered TH activity (Wallis et
al., 2012). Lphn3 null mice demonstrate striatal and PFC alterations in the expression of
DA transporter gene Slc6a3 (Mortimer et al., 2019; Orsini et al., 2016), which is
significant as this gene is associated with ADHD (Pramod, Foster, Carvelli, & Henry,
2013). Thus, it seems likely that attenuated Lphn3 expression might impose a dampening
effect on DA dependent neurotransmission.
Down-regulation of Lphn3 has been shown to impact behavior in a way that
closely mirrors ADHD symptomology. Down regulation of Lphn3 function in zebrafish
models has been shown to induce behavioral changes similar to the ADHD phenotype
such as increased locomotion, night-time hyperactivity, and episodes of motor
impulsivity (Lange et al., 2012). More recently, Reuter et al. (2016) further confirmed the
role of Lphn3 expression on hyperactivity in a zebrafish model by comparing Lphn3
knock-downs and wild types. Hyperactivity of the Lphn3 knock-down zebrafish
population in this study was indicated by significantly increased swimming distance and
an increase in switching between locomotor activity types. Additionally, Lphn3 null
mutant rodent populations have been shown to exhibit robust increases in locomotor
hyperactivity that is independent of age and/or sex (Wallis et al., 2012). Interestingly, the
behavioral abnormalities seen in Lphn3 animal models are rescued by the commonly
prescribed ADHD medications methylphenidate (MPH) and atomoxetine (ATO) (Orsini
et al., 2016). For example, Lange et al. (2012) was able to successfully restore previously
hyperactive Lphn3 morphants to control activity levels via exposure to MPH and ATO.
The link between Lphn3 variants and ADHD-like behavioral deficits has been replicated
in human populations from Colombia, Germany, Norway, Spain, the United States,
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Canada, Brazil, and Korea (Acosta et al., 2016). In fact, pharmacogenetic studies done on
these populations concluded that Lphn3 variants not only predisposed individuals to
ADHD, but also predicted how well these individuals would respond to stimulant
medications (Acosta et al., 2016; Martinez et al., 2016). Additional studies on human
populations have demonstrated that Lphn3 variants serve as biomarkers for ADHD
severity, long-term prognosis, and also predict patterns of brain metabolism (Martinez et
al., 2016; Orsini et al., 2016). The temporal and spatial parallels shared between ADHD
pathology and Lphn3 expression are also quite interesting. More specifically, Lphn3
expression appears to be limited to neural structures that have been previously implicated
in ADHD, and Lphn3 is more robustly expressed early on in development while
expression of the gene decreases as the brain matures (Arcos-Burgos & Muenke, 2010).
While these studies seem to suggest the existence of a relationship between Lphn3
variations, ADHD symptomology, and DA dependent neurotransmission, a precise
mechanism for both the neurobiological and behavioral consequences remains unknown.
Purpose and Hypotheses
As mentioned above, more research is needed to evaluate the impact of varied
Lphn3 gene expression on the core behavioral symptoms of ADHD (i.e., inattentiveness,
hyperactivity, and impulsivity) to determine the face validity as an animal model of
ADHD. Recently, researchers at Cincinnati Children’s Medical Center recently
developed a Lphn3-/- (i.e., knockout) rat. Unlike the Lphn3 null mouse and zebrafish
models, the rat model allowed for analysis of more sophisticated behavioral measures of
ADHD symptomology, with the goal of associating these behavioral measures to
pharmacological measures of catecholamine function later-on. This project represents the
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first step in this process, whereby impulsive action and impulsive choice were evaluated
in Lphn3-/- knockout (KO) rats versus Lphn3+/+ wildtype (WT) controls. Specifically, a
DRL task was used to evaluate impulsive action and a delayed discounting (DD) task was
used to evaluate impulsive choice. It was hypothesized that Lphn3 KO rats would exhibit
impaired performance on both measures of impulsivity.
Methods
Subjects
Subjects consisted of 5 (N=5) male and 5 (N=5) female Lphn3-/- rats on a
Sprague-Dawley background and 6 (N=6) male and 5 (N=5) female Lphn3+/+ WT
controls generated in the Cincinnati Children’s Transgenic Animal and Genome Editing
Core using CRISPR/Cas9 to delete exon 3. The mutant rats were generated by injection
of two sgRNAs (50 ng/µL each) and Cas9 mRNA (100 ng/µL), along with two ssDNA
donor oligos that contained loxP (50 ng/µL each), into the cytoplasm of fertilized eggs.
The injected embryos were immediately transferred into the oviductal ampulla of
pseudopregnant females. The resulting founders were bred with wildtype (WT) rats to
establish the lines and Lphn3+/- x Lphn3+/- crossings were used for generating the KO
and WT rats for this experiment. Ear punches were collected from offspring at P7 for
genotyping. Rats were housed in same-sex pairs in a temperature-controlled environment
(21 ± 1℃) on a 12 hour reverse light/dark cycle (lights on at 0700 hr) with food and
water available ad libitum. All procedures were approved by the University of Memphis
Institutional Animal Care and Use Committee and performed in accordance with the
National Institutes of Health and Guidelines for the Care and Use of Laboratory Animals.
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Apparatus
Behavioral testing was conducted in 10 operant chambers that were each housed
in sound attenuating boxes (Med Associates; St. Albans, VT). Each operant chamber was
equipped with two symmetrically placed cue lights each over a retractable lever, a house
light fixed opposite the cue lights, and a food trough placed between the two retractable
levers. A white noise frequency was delivered to eliminate any extraneous noise. All
operant programs were controlled via a PC equipped with Med-PC IV software (Med
Associates) and all data generated were stored on the same computer and backed up to a
remote server.
Procedure
Impulsivity Testing. Each rodent was assessed on two different operant measures of
impulsivity that have been shown to be sensitive to proper catecholamine activity in the
PFC (Dalley et al., 2008). First, a differential responding of low rates (DRL) task was
used to assess impulsive action (Meyer, Miller, Nelms Sprowles, Levine, & Sable, 2015;
Sable et al., 2009; Sable, Powers, Wang, Widholm, & Schantz, 2006) followed by a delay
discounting (DD) task to examine impulsive choice (Simon et al., 2013; Simon, Mendez,
& Setlow, 2007). The procedures that were used to train animals as well as the
parameters for the DRL and DD tasks are described below. All rats began food restriction
on PND 60 and were maintained between 85-90% of free-feeding weight including
adjustments based on the projected growth curves for each strain. Testing began on PND
70 and occurred 7 days/week and lasted for approximately 3.5 months. Testing was done
at the same time each day beginning at approximately 0900 hr.
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Autoshaping. During autoshaping, both levers were made available to the rat, and every
press on either lever resulted in the delivery of a 40 mg grain-based dustless precision
food pellet (Bio Serv; Frenchtown, NJ). If no lever press occurred within 3 minutes, a
free 45 mg reward pellet (Bio Serv; Frenchtown, New Jersey) was dispensed into the
food magazine to entice the rat to explore the operant box and to press the levers.
Autoshaping sessions persisted until either 100 reinforcers were delivered or 60 min
elapsed. Autoshaping required an average of two test sessions per rodent.
Fixed Ratio Training. After autoshaping, rats were placed on a fixed-ratio (FR) schedule
of reinforcement in order to strengthen the previously conditioned lever-pressing
behavior. At the start of each FR session, the right response lever only was presented, and
the right cue light illuminated. Each lever press resulted in the delivery of a food pellet
into the food magazine. After five food pellets were dispensed by pressing the right lever,
the cue light over this lever was extinguished, the lever retracted, and the opposite lever
and cue light activated. After five reinforcers were earned, the active lever was switched
back to the other lever. The criterion for completing FR training was 100 earned
reinforcers for at least two consecutive sessions. FR training lasted an average of three
sessions per rodent.
Differential Reinforcements of Low Rates (DRL). Details of these procedures are
discussed elsewhere (Meyer et al., 2015; Sable et al., 2009; Sable et al., 2006). Briefly,
rats were first tested on an initial DRL5 task for two days during which only the right
lever was extended. After pressing the lever to start the trial, a 5 s inter-response time
(IRT) was required before a second lever press to earn a subsequent food reward.
Premature lever presses that occurred before the 5 s IRT had elapsed resulted in
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termination of that trial and no reinforcer being delivered. Following DRL5, rats were
tested on a DRL10 task for two days during which a 10 s (IRT) was required to occur
before a subsequent food reward was earned. Following DRL10, rats were tested on a
DRL15 task for 30 days which required 15 s between lever presses. The penalty for
premature responses during DRL 10 and DRL 15 were the same as during DRL5.
Magazine Training. In preparation for DD, rats were trained over a single session to
poke in the food magazine to begin each trial. Each successful nose poke resulted in
delivery of a food pellet.
Delayed Discounting (DD). Details of these procedures have also been explained
previously (Simon et al., 2013) and were adapted from Evenden and Ryan (1996) and
Simon et al. (2007). Each session had five testing blocks. Each block began with two
forced choice trials. A nose-poke into the food magazine resulted in illumination of the
cue lights located above each response lever but extension of only one of the response
levers. A press on this lever (either right or left, balanced across rats) resulted in the
delivery of a single food pellet, immediately. A nose poke into the magazine began the
second trial in which both cue lights were illuminated but the other lever presented. A
press on this other lever resulted in the delivery of three food pellets but only after a
delay of 0, 4, 8, 12, or 16 sec. Delays were kept consistent within each trial block (i.e., 5
trials/block), with the length of the delay increasing progressively across testing block. If
a response did not occur within 60 seconds, that trial was counted as an omission. Rats
were tested for 25 sessions (1 session/day). DD performance was averaged into five-day
testing blocks and the average choice of larger reward determined across each of the five
delays for the first and last 5-day testing block.
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Design
DRL. Dependent measures for DRL included the ratio of reinforced:nonreinforced lever
presses, the number of reinforcers delivered, and proportion of responses falling within
specified 2.5 sec inter-response time (IRT) bins. For DRL 5 and DRL 10, the reinforced:
non-reinforced ratio and number of reinforcers delivered were analyzed via a 2
(genotype) x 2 (sex) x 2 (day) mixed ANOVA with day as the repeated measures factor.
Data from the 30 days of DRL testing was averaged into 6, 5-day testing blocks and this
was included as a repeated-measures factor instead of day. Response pattern analysis for
DRL5 and DRL was analyzed for both testing days via a genotype x sex x day x IRT bin
mixed ANOVA with day and IRT bin as the repeated measures factors. For DRL 15,
reponse pattern analysis of the first 5 day-testing block (i.e., acquisition) and last 5-day
testing block (i.e., maintenance) were analyzed separately via a 2 (genotype) x 2 (sex) x 8
(IRT bin) mixed ANOVA.
DD. The percent choice for the larger, delayed reinforcer at each delay was calculated for
each testing session and averaged into 5, 5-day testing blocks and analyzed via a 2
(genotype) x 2 (sex) x 5 (delay) x 5 (block) mixed ANOVA with delay and block as the
repeated measures factors. In addition, the area under the curve (AUC) and the slope of
percent choice for the delayed reinforcer was analyzed separately via a 2 (genotype) x 2
(sex) between-subjects ANOVA on data from the final testing block.
Results
DRL 5
Reinforced:Non-reinforced Responses. A significant genotype x day interaction on the
ratio of reinforced:non-reinforced responses was found, F(1,17)=4.669, p=.045. Post hoc
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analysis comparing the genotypes on each day of testing revealed WT rats had a higher
proportion of reinforced: nonreinforced responses compared to KO rats only on the
second day of DRL5, but the difference only approached the threshold for significance
(p=.059, Figure 1).
Reinforcers Earned. The genotype x day interaction on the number of reinforcers earned
approached the criterion for statistical significance, F(1,17)=3.279, p=.088. No other
genotype- or sex-related effects were found. (Data not shown.)
Inter-response Times. The omnibus ANOVA revealed a significant genotype x day x
IRT interaction, F(3,51)=4.431, p=.008. Post hoc analyses comparing the genotypes at
each IRT separately on each testing day found no significant differences on day 1 (Figure
2). However, on day 2, Lphn3-/- rats demonstrated a higher proportion of responses within
the <2.5 s IRT bin (p=.022, Figure 3).
DRL 10
Reinforced:Non-reinforced Responses. The omnibus ANOVA did not reveal any
significant genotype- or sex-related effects. Although the WT rats exhibited a higher ratio
of reinforced:non-reinforced responses (especially on day 2), neither the main effect of
genotype nor the genotype x day interaction was statistically significant (Figure 4).
Reinforcers Earned. The omnibus ANOVA did not reveal any significant genotype- or
sex-related effects on the number of reinforcers earned. (Data not shown.)
Inter-response Times. The mixed ANOVA revealed a significant genotype x IRT
interaction on the proportion of responses within each IRT bin, F(5,85) = 8.311, p< .001.
Post hoc analyses comparing the genotypes at each IRT averaged across each testing day
revealed that during the < 2.5 s IRT bin, Lphn3-/- rats exhibited a greater proportion of
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responses (p = .002). However, during the 5-7.5 s IRT bin, WT rats exhibited a greater
proportion of responses (p = .001, Figure 5).
DRL 15
Reinforced:Non-reinforced Responses. The mixed ANOVA revealed a significant main
effect of genotype on the variable of reinforced:non-reinforced responses, F(1,17)=4.741,
p = .044. WT rats exhibited a higher proportion of reinforced:non-reinforced responses
across all testing blocks compared to the KO rats (Figure 6).
Reinforcers Earned. There were no genotype-related effects on the number of reinforcers
earned (Figure 7). There was, however, a significant main effect of sex, F(1,17)=5.856,
p=.027. Specifically, males earned significantly more reinforcers than females (Figure 7,
inset).
Inter-response Times. In order to distinguish between task acquisition (ability to learn a
task) and maintenance (general ability to perform the task once maximal learning has
occurred), performance was analyzed separate for the first 5 days (i.e., acquisition) versus
the last 5 days (i.e., maintenance).
Block 1 (Acquisition). During the first 5-day testing block, the mixed ANOVA
revealed a significant main effect of sex, F(1,17)=4.949, p=.040, and significant
interactions of genotype x IRT, F(7,119)=9.235, p< .001, sex x IRT, F(7,119)=2.821,
p=.009, and genotype x sex x IRT, F(1,119)=2.102, p=.048. The male KO rats had a
significantly higher proportion of responses during the shorter IRT bins, but a lower
proportion of responses during higher IRT bins. Post hoc analyses revealed that the
difference between the KO and WT rats was significant only during the 10.0-12.5 s bin
(p=.049, Figure 8). Like the males, the KO females had a lower proportion of responses
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during the shortest IRT bin (p=.001). while for all of the other IRT bins, the WT rats had
a higher proportion of responses with the difference being significant within the 5.0-7.5 s
bin (p=.019, Figure 9).
Block 6 (Maintenance). During the last 5-day testing block, the mixed ANOVA
revealed significant interactions of genotype x IRT, F(7,119) = 8.357, p<.001, and
genotype x sex x IRT, F(7,119) = 3.166, p=.004. Post hoc analysis in the males revealed
that during the very last IRT interval (i.e., >17.5 s), WT males had a significantly higher
proportion of responses than the KO males (p=.016, Figure 10). In the females, the KO
rats had a significantly higher proportion of responses during the first 2.5 s interval
(p<.001) compared to WT rats. Conversely, female WT rats had a significantly higher
proportion of responses during the 5.0-7.5 s (p=.022), 7.5-10.0 s (p=.024), 10.0-12.5 s
(p=.034), and 12.5-15.0 s intervals (p=.005, Figure 11).
Delayed Discounting
Omnibus analysis of percent choice for larger delay.
The mixed ANOVA on the percent choice for the larger reward revealed a
significant main effect of delay, F(4,14)=46.498, p<.001. Specifically, as the length of
the delay increased, rats selected the larger reward less than the smaller, immediate
reward (Figure 12). Additionally, the main effect of genotype approached statistical
significance, F(1,17)=4.220, p=.056. It should be noted, that this effect was accompanied
by a large effect size (Cohen, 1998) with η2p = .199. Interestingly, the KO rats opted for
the lever associated with the larger, delayed reward more than the WT rats did (Figure
13).
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Task acquisition vs. Maintenance. As was done for DRL, performance during task
acquisition and maintenance were evaluated separately.
Block 1 (Acquisition). Across the first 5 days of testing, analysis of the percent
choice for the larger reward revealed a significant main effect of delay, F(4,14)=10.434,
p<.001, with the percent choice for the delayed reward decreasing as the delay increased
(Figure 14). A significant main effect of sex was also found, F(1,17) = 8.316, p=.010.
Females selected the larger, delayed reward at a higher percentage than the males (Figure
15). Additionally, a genotype x sex interaction was found, F(1,17) = 4.653, p=.046.
While male and female WTs performed similarly, female KO rats selected the delayed
reward significantly more than their male counterparts (Figure 16).
Block 5 (Maintenance). Across the last 5 days of testing, analysis of the percent
choice for the larger reward again revealed a significant main effect of delay, F(4,14)=
31.677, p<.001. As was the case during acquisition, rats selected the larger reward less as
the delay increased (Figure 17). Moreover, this effect was more pronounced during
maintenance than during acquisition (Figure 15 versus Figure 17). A significant main
effect of genotype was also found, F(1,17)=5.788, p=.028. The KO rats selected the
larger, delayed reward more often than their WT counterparts (Figure 18).
The discounting curves for each animal separated by genotype and testing phase
(i.e., acquisition versus maintenance) are presented in Figure 19. Data from the males is
represented by the solid lines while females are represented by the dashed lines. These
data appear to support the previously mentioned significant genotype x sex interaction
and genotype main effect observed during acquisition and maintenance, respectively.
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Slope of percent choice. Analysis of the slope of the discounting curve (i.e., percent
choice for the delayed reward) during the maintenance phase (i.e., last 5 days) of testing
did not reveal any statistically significant genotype or sex-related differences. (Data not
shown.)
Area under the curve. The analysis of area under the curve during the maintenance phase
(last 5 days) revealed a significant main effect of genotype, F(1,17) = 5.510, p=.031.
Surprisingly, the area under the curve was greater for Lphn3-/- rats (Figure 20).
Discussion
Dissociation of Impulsive Action Versus Impulsive Choice
The DRL results supported the hypothesis that Lphn3 KO rats would exhibit
impaired performance. Overall, the WT rats exhibited a higher proportion of reinforced:
nonreinforced responses compared to the KO rats. Common to all three DRL schedules
was an increase in “burst” responding (Bradley, 1971) by the KO rats. Burst responding
may be indicative of enhanced, global locomotor activity (Kirshenbaum, Brown, Hughes,
& Doughty, 2008), a perseverative response driven by a lack of exteroceptive feedback
for previous unreinforced responses (Farmer & Schoenfeld, 1964), or a deficit in
response inhibition (Manfre, Nguyen, Doyere, & El Massioui, 2014). Notably, the
number of reinforcers earned did not differ between the genotypes. Because short IRT
responses were not reinforced, KO rats were required to complete more trials to obtain
the same number of reinforcers.
The DD results found in this study did not support the hypothesis. It was
originally hypothesized that the KO rats would exhibit impaired performance (i.e., greater
discounting of the larger, delayed reward) compared to the WT rats. However, the KO
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rats (especially the females) discounted the larger, delayed reward significantly less than
the WT rats. Such results indicate that impulsive choice was not increased by Lphn3
deletion.
Taken together, the dissociation between the DRL and DD results provides
additional evidence that impulsivity is a multi-faced construct. While impulsive action
and impulsive choice are widely recognized facets of the singular construct of
impulsivity, past studies have suggested that these two modalities are, in fact, distinctly
separate and can be teased apart with the appropriate behavioral assays in both clinical
and preclinical settings. For example, in a translational study, Broos et al. (2012) tested
rats and human subjects on a measure of impulsive action and a measure of impulsive
choice. For both the animal and human data, the two measures of impulsivity were not
correlated. This relationship was further evaluated with subsequent pharmacological
manipulations in the rat sample. ATO and AMPH were administered prior to tests of
impulsive action and impulsive choice. Atomoxetine decreased premature responses in
the impulsive action task, but also increased impulsive choice in a DD task. AMPH, on
the other hand, increased premature responses, but decreased impulsive choice in the
same animals. Additional studies concerning pharmacological influence on measures of
impulsivity have corroborated these findings by demonstrating differential effects of
amphetamine on impulsive choice and impulsive action (Cardinal, Robbins, & Everitt,
2000; Wiskerke et al., 2011). Likewise, numerous other factors such as sleep deprivation
(Demos et al., 2016), subject/participant sex (Weafer & de Wit, 2014), age at the time of
testing (Cho, Kwak, Kim, & Kim, 2018), social enrichment (Wang, Marshall, &
Kirkpatrick, 2017), and chronic corticosterone administration (Torregrossa, Xie, &
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Taylor, 2012) have all been shown to differentially impact impulsive action and
impulsive choice.
Relevance to ADHD
The performance deficit observed in the KO rats during DRL is meaningful, as it
is similar to the behavioral disinhibition (i.e., impulsive action deficits) seen in
individuals with ADHD (Malloy-Diniz, Fuentes, Leite, Correa, & Bechara, 2007;
Winstanley, Eagle, & Robbins, 2006). On the other hand, the KO rats were not impaired
during DD and did not demonstrate any type of impairment in impulsive choice. Deficits
in DD in individuals with ADHD have been frequently reported (see Patros et al., 2016
for a review). Interestingly, if the total length of time the participant has to spend on the
task does not change based on which type of reward is chosen, the percent choice for the
delayed rewards does not differ between controls and ADHD individuals (Sonuga-Barke,
Taylor, Sembi, & Smith, 1992). Interestingly, our study used this approach, whereby each
trial lasted for the duration of the larger reward delay, even if the smaller, immediate
reward was chosen. Perhaps this is one reason why the KO rats did not discount the
larger, delayed reward. One alternative explanation is that when the trial lengths are not
consistent, ADHD individuals will choose the immediate reward in order to avoid delay
and/or escape from the task more quickly (Sonuga-Barke, 2002, 2003). This appears to be
more a deficit of impulsive action than impulsive choice.
Limitations
While the current study did demonstrate overall discounting of the delayed
reward, it is possible that the delays used (i.e., maximum delay was 16 s) were not long
enough to induce impulsive choice. This explanation can be directly assessed in a follow-
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up study comparing Lphn3 KO and WT rats on a DD task using longer delays (e.g., 0, 4,
8, 16, 32 s). If the Lphn3 KO rats exhibit impulsive choice, this would indicate the delays
used in the current study were not long enough. If the KO rats do not exhibit impulsive
choice, these results would suggest the KO rats do not have an impulsive choice deficit.
A second limitation is that the DD task occurred immediately after DRL testing.
DRL testing was conducted using only the right response lever, while DD required the
use of both levers. As DRL promoted a low response rate on the right lever, this may
have had an influence on the percent choice for the larger, reward especially if the larger
reward was associated with the right lever. Recall that which lever was associated with
the larger, delayed reward was counterbalanced across genotype and sex. Thus, we were
able to analyze whether the discounting curves differed depending on whether the larger,
delayed reward was associated with the left or right lever. The results of this analysis
revealed a similar discounting curve regardless of which lever was associated with the
delayed reward. Future research could avoid this issue altogether, by conducting DD
testing prior to DRL or using a different response requirement (e.g., nosepoke) during
DD testing.
Future Directions
Vary the trial length during DD. In addition to increasing the reward delays as described
above, it would also be interesting to compare fixed versus varied trial lengths during DD
testing to assess whether this has an impact on the percent choice for the larger, delayed
reward. If each trial ends and the next trial begins immediately thereafter, KO rats may
opt to choose the immediate reward to avoid the delays and end the session sooner.
However, if the trial length is fixed regardless of choice and the KO rats now select the
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delayed reward, this would provide additional evidence for a deficit in impulsive action,
not impulsive choice.
Examine the effects of ADHD medications on DRL and DD. In line with previous
studies examining the effects of AMPH and ATO on impulsive action and impulsive
choice (e.g., Broos et al., 2012), future studies could also assess whether these two
ADHD pharmacotherapies differentially affect DRL and DD performance, thereby
providing further evidence that impulsive action and impulsive choice are unique facets
of impulsivity with unique neurobiological correlates.
Conclusions
The present findings suggest a clear relationship between variation in Lphn3 gene
expression and impulsive action. In particular, Lphn3 deletion appears to impair the
ability to inhibit an inappropriate response to prepotent stimuli. However, the impact that
Lphn3 mutation imposes on the construct of impulsive choice is less clear. Overall, the
current study corroborates research proposing that impulsive action and impulsive choice
are unique facets of impulsivity but raises questions about whether performance on
discounting tasks in ADHD individuals accurately represents deficits in impulsive choice.
Overall, the current findings necessitate the importance of future studies to better
understand the neurobehavioral, neuroanatomical, and neurochemical correlates
underlying the different facets of impulsivity, as well as how variations in Lphn3 gene
expression influence these outcomes.
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Figure 1. The ratio of reinforced:nonreinforced responses on DRL5 as a function of
genotype and testing day. Wildtype (WT) rats had a higher ratio of reinforced:
nonreinforced responses as compared to KO rats on the second day of DRL5, but the
difference only approached the threshold for statistical significance (p = .059).
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Figure 2. The proportion of responses as a function of IRT bin (2.5 s intervals) and
genotype on the first day of DRL 5. There was not a difference between the genotypes
within any of the IRT bins.
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Figure 3. The proportion of responses as a function of IRT bin (2.5 s intervals) and
genotype on the second day of DRL 5. During the first <2.5 s IRT bin, KO rats exhibited
a significantly higher proportion of responses as compared to WT rats, p=.022.
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Figure 4. The ratio of reinforced: nonreinforced responses on DRL10 as a function of
genotype and testing day. Although the WT rats exhibited a higher ratio on both testing
days, neither the main effect of genotype nor the genotype x day interaction was
statistically significant.
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Figure 5. The proportion of responses as a function of IRT bin (2.5 s intervals) and
genotype averaged across both days of DRL10. Within the first 2.5 s interval, KO rats
had a higher proportion of responses than the WT rats (p=.002), while WT rats had a
higher proportion than KO rats during the 5.0-7.0 s interval (p=.001).
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Figure 6. The ratio of reinforced:nonreinforced responses during DRL 15 as a function of
genotype and testing block (ie., 5-day average). Overall, WT rats exhibited a higher
proportion of reinforced:nonreinforced responses s compared to the KO rats (p=.044).
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Figure 7. There was not a significant difference between the genotypes on the total
number of reinforcers earned, nor a significant genotype x testing block interaction.
Inset. Overall, male rats earned significantly more reinforcers compared to females
(p=.027).
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Figure 8. The proportion of responses in each IRT bin during block 1 (acquisition) for the
males. KO rats had a significantly higher proportion of responses during the shorter IRT
bins, but a lower proportion of responses during longer IRT bins. This difference was
significant in the 10.0-12.5 s bin (p=.049).
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Figure 9. The proportion of responses in each IRT bin during block 1 (acquisition) for the
females. Like the males, the KO females had a higher proportion of responses during the
shortest IRT bin (p=.001). For all other bins, the WT rats had a higher proportion of
responses with the difference being significant within the 5.0-7.5 s bin (p=.019).
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Figure 10. The proportion of responses in each IRT bin during block 6 (maintenance) for
the males. During the very last IRT interval, WT males had a significantly higher
proportion of responses than the KO males (p=.016).
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Figure 11. The proportion of responses in each IRT bin during block 6 (maintenance) for
the females. During the first 2.5 s interval, female KO rats had a significantly higher
proportion of responses compared to female WT rats, p<.001. Conversely, female WT
rats had a significantly higher proportion of responses during the 5.0-7.5 s (p=.022), 7.510.0 s (p=.024), 10.0-12.5 s (p=.034), and 12.5-15.0 s intervals (p=.005).
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Figure 12. The percent choice for the larger reward averaged across all days of DD
testing as a function of reward delay. The larger, delayed reward was selected less often
(ie., was discounted) as the delay increased. (Main effect of delay, p<.001).
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Figure 13. The percent choice for the delayed reward as a function of genotype. The KO
rats opted for the lever associated with the larger, delayed reward more than the WT rats
did (p=.056, η2p = .199).
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Figure 14. Across the first 5 days of testing (i.e., acquisition), the percent choice for the
delayed reward decreased as the delay increased. (Main effect of delay, p<.001.)
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Figure 15. Across the first 5 days of testing (i.e., acquisition), the percent choice for the
larger, more delayed reward was higher overall in the females versus the males (p=.010).
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Figure 16. Across the first 5 days of testing (i.e., acquisition), the percent choice for the
larger, more delayed reward between the genotypes did not differ as a function of sex.
However, female KO rats chose the delayed reward more often compared to male KO
rats, p=.010.
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Figure 17. Across the last 5 days of testing (i.e., maintenance), the percent choice for the
delayed reward decreased as the delay increased. (Main effect of delay, p<.001.)
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Figure 18. Across the last 5 days of testing (i.e., maintenance), the percent choice for the
larger, more delayed reward was higher overall in the KO rats versus the WT rats (p
=.028).
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Figure 19. Delay discounting for each rat tested divided by genotype and sex.
Acquisition data was from the first 5 days of testing while maintenance data was from the
last 5 days of testing. Solid lines = males; dashed lines = females.
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Figure 20. Area under the curve as a function of genotype. KO rats exhibited a greater
area under the curve as compared to WT rats (p=.031).
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